MHRA unveils medicine information resource

September 29, 2008
Medical Communications patients

UK regulators and the pharma industry have come together to launch a new website for patients. The 'mymedicine' site is …

Pradaxa approved by NICE

September 26, 2008
Sales and Marketing NICE, Pradaxa, clot, cv

NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …

Lilly to reveal doctor payments

September 26, 2008
Medical Communications, Sales and Marketing ethics

Lilly is to be the first pharmaceutical company to disclose payments made to US doctors for consultancy services and key …

Merck’s Kuvan set for European approval

September 26, 2008
Sales and Marketing EU, Kuvan

Merck Serono's Kuvan is on track to become the first medicine approved in Europe for two rare neurological disorders. Regulatory …

Working Life: Ali Ross

September 25, 2008
Medical Communications, Sales and Marketing Europe, Otsuka, communications

How did you find your way into this role?

Gardasil and Cervarix share innovation prize

September 25, 2008
Sales and Marketing Cancer, Gardasil, prix galien, vaccines

Rival vaccine products that will prevent thousands of women developing cervical cancer have been declared joint winners of the prestigious …

Brown to scrap prescription costs for cancer patients

September 24, 2008
Cancer, NHS

Patients suffering from cancer won't have to pay for prescriptions after April next year under new government plans. Prime minister …

Sanofi seals Zentiva deal with improved offer

September 23, 2008
Sales and Marketing MA, Sanofi, generics

Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …

Pharma and the High Street health shop

September 23, 2008
Sales and Marketing industry relations, pharmacy

The April publication of the long-awaited pharmacy White Paper – 'Building on Strengths, Delivering the Future' – spells exciting times …

Latest news from Datamonitor

September 23, 2008
biotech

Monoclonal antibody sales to almost double by 2013In 2007, total global monoclonal antibody sales reached $26 billion and are forecast …

Giuliani to argue Ranbaxy’s case in US

September 18, 2008
Sales and Marketing US, generics

Indian generics firm Ranbaxy has hired former New York mayor Rudolf Giuliani to help reverse an FDA block on imports …

Once-daily Seroquel launched

September 18, 2008
Sales and Marketing AZ, psych

AstraZeneca has launched a once-daily version of Seroquel in the UK. The drug is used to treat schizophrenia and manic …

Ban on ‘top-up’ payments for drugs not working

September 18, 2008
Sales and Marketing NHS, par

The King's Fund says the current ban on NHS patients paying privately for 'top-up' drugs is not working. The Department …

Working Life: Amanda Moosa

September 18, 2008
Business Services, Sales and Marketing Nycomed, Working Life, branding, careers, marketing, sales

 How did you find your way into your current role?I came into things via the ‘traditional’ route. After my biochemistry …

The Pharmafocus Interview: Andrew Dillon

September 17, 2008
Research and Development, Sales and Marketing NHS, NICE, hc

NICE's rejection of four new cancer drugs predictably provoked the ire of campaigners, again raising unfavourable comparisons with European uptake …

GSK seeks risk-sharing deal for Tyverb

September 17, 2008
Sales and Marketing Cancer, GSK, NICE, par

GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …

PCTs told to explain how drug funding decisions are reached

September 17, 2008
NHS, hc

The Department of Health has written to PCT chief executives requesting information on how they reach funding decisions on new …

Paolo

GSK unveils new cancer unit

September 17, 2008
Research and Development Cancer, GSK

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …

Amgen sells off two biotech products

September 16, 2008
Research and Development biotech

Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …

Latest news from Datamonitor

September 15, 2008
Sales and Marketing NICE, rcc

UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …

The Gateway to Local Adoption Series

Latest content